Page:Washington v. U.S. Food and Drug Administration (Order on Motion for Clarification, Apr. 13, 2023).pdf/6

Case 1:23-cv-03026-TOR ECF No. 91 filed 04/13/23 PageID.2252 Page 6 of 6

1. “altering the status quo and rights as it relates to the availability of Mifepristone under the current operative January 2023 Risk Evaluation and Mitigation Strategy under 21 U.S.C. § 355-1 in Plaintiff States and the District of Columbia.”

The District Court Executive is directed to enter this Order and furnish copies to counsel.

DATED April 13, 2023.

THOMAS O. RICE
United States District Judge

ORDER GRANTING MOTION FOR CLARIFICATION ~ 6